Three Indian Drug Makers Selling Lipitor Generics In U.S. Drive Price Down
This article was originally published in PharmAsia News
Executive Summary
So many Indian makers of generics are set to market their own versions of Pfizer’s popular Lipitor (atorvastatin) cholesterol drug, both new and old suppliers to the U.S. can expect pressure for lower prices.